GlassScriptPhysician profile
Anna Pudinak
NPI 1952665200
$20,194.12
in general payments reported to CMS, 2019-2025
57 companies · $3,595 in 2025
The $3,595 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,550 · 2020: $2,222 · 2021: $3,441 · 2022: $2,123 · 2023: $3,228 · 2024: $3,035 · 2025: $3,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,857.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,190.94 | 2020-2025 | |
| Novo Nordisk INC | $2,023.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,792.42 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $1,364.06 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Biohaven Pharmaceuticals, INC. | $1,360.45 | 2021 | |
| Amgen INC. | $1,359.54 | 2019-2025 | Repatha, Otezla, Repatha |
| Allergan, INC. | $762.11 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $632.38 | 2019-2025 | Airsupra, Farxiga |
| Teva Pharmaceuticals USA, INC. | $616.07 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Janssen Pharmaceuticals, INC | $531.85 | 2019-2025 | Spravato |
| Ironwood Pharmaceuticals, INC | $417.41 | 2019-2024 | Linzess |
| Pfizer INC. | $396.45 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $375.36 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $341.46 | 2020-2025 | Jardiance |
| Alk-Abello, INC | $293.68 | 2019-2025 | Odactra, Ragwitek, Grastek |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $270.02 | 2025 | Auvelity, Symbravo |
| Mannkind Corporation | $259.36 | 2019-2023 | Afrezza |
| Tolmar, INC. | $224.20 | 2023-2025 | Jatenzo |
| Kowa Pharmaceuticals America, INC. | $206.54 | 2024-2025 | Zoryve |
| Intra-Sana Laboratories | $179.45 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Stryker Corporation | $166.54 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Dexcom, INC. | $165.69 | 2023-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $161.73 | 2019-2021 | |
| Impel Pharmaceuticals INC. | $146.22 | 2023 | Trudhesa |
| Esperion Therapeutics, INC. | $139.04 | 2020-2024 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $137.10 | 2022 | |
| Scilex Pharmaceuticals INC. | $135.12 | 2021-2025 | Ztlido |
| Glaxosmithkline, LLC. | $134.58 | 2021-2024 | Trelegy Ellipta |
| Azurity Pharmaceuticals, INC. | $128.78 | 2023-2025 | Horizant, Alvesco, Edarbi |
| Bard Peripheral Vascular, INC. | $125.00 | 2022 | |
| Abbott Laboratories | $102.65 | 2022-2024 | Freestyle Libre 3 |
| Angiodynamics, INC. | $102.30 | 2019 | |
| Sanofi-Aventis U.S. LLC | $95.30 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $83.15 | 2025 | Rexulti |
| Amarin Pharma, INC. | $82.41 | 2019-2021 | |
| Horizon Therapeutics Plc | $80.46 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $77.44 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $64.36 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $46.52 | 2021-2024 | Contrave |
| Genentech USA, INC. | $39.28 | 2020-2021 | |
| Astellas Pharma US INC | $38.14 | 2024-2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $38.06 | 2023-2024 | Gvoke Hypopen |
| Ardelyx, INC. | $33.10 | 2023-2024 | Ibsrela |
| Vivus LLC | $32.00 | 2022-2023 | Qsymia |
| Dermira, INC. | $30.00 | 2020 | |
| Ibsa Pharma INC. | $28.30 | 2023-2024 | Tirosint, Tirosint, Licart |
| Ge Healthcare | $24.80 | 2021-2022 | |
| Ucb, INC. | $21.68 | 2025 | Bimzelx |
| Sanofi Pasteur INC. | $20.15 | 2023 | |
| Medicure Pharma INC. | $16.67 | 2022 | |
| Boston Scientific Corporation | $16.31 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.87 | 2022 | |
| Impel Pharmaceuticals LLC | $14.70 | 2025 | Trudhesa |
| Vistapharm, INC. | $14.34 | 2021 | |
| Exeltis, USA INC. | $14.18 | 2024 | Slynd |
| Alfasigma USA, INC. | $13.16 | 2022 | |
| Gilead Sciences, INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pudinak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.